Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 45,239 | 53,250 | 45,839 | 37,271 | 4,030 |
| Cost of Goods | 25,706 | 31,013 | 25,979 | 18,791 | 750 |
| Gross Profit | 19,533 | 22,237 | 19,860 | 18,480 | 3,280 |
| Operating Expenses | 27,268 | 25,345 | 27,320 | 20,201 | 7,202 |
| Operating Income | -7,735 | -3,108 | -7,460 | -1,721 | -3,922 |
| Interest Expense | 822 | 2,266 | 3,156 | N/A | N/A |
| Other Income | 25,702 | 19,980 | 99 | -1,400 | 2,244 |
| Pre-tax Income | 17,145 | 14,606 | -10,517 | -3,121 | -1,678 |
| Income Tax | -347 | -906 | -1,040 | 32 | 1,281 |
| Net Income Continuous | 17,492 | 15,512 | -9,477 | -3,153 | -2,959 |
| Minority Interests | 602 | 1,937 | 7,768 | N/A | N/A |
| Net Income | $18,094 | $17,449 | $-1,709 | $-6,669 | $-2,959 |
| EPS Basic Total Ops | 0.14 | 0.13 | -0.01 | -0.05 | -0.02 |
| EPS Basic Continuous Ops | 0.14 | 0.13 | -0.01 | -0.05 | -0.02 |
| EPS Diluted Total Ops | 0.14 | 0.13 | -0.01 | -0.05 | -0.02 |
| EPS Diluted Continuous Ops | 0.14 | 0.13 | -0.01 | -0.05 | -0.02 |
| EBITDA(a) | $25,052 | $24,486 | $402 | $37,424 | $-3,386 |